These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 38508563)
1. The regulation of CuSNPs' interface for further enhancing mechanical and photothermal conversion properties of chitosan/@CuSNPs hybrid fibers. Liu Z; Bao D; Jia S; Qiao J; Xiang D; Li H; Tian L; Zhang B; Zhang X; Zhang H; Guo J; Zhang S Int J Biol Macromol; 2024 Apr; 265(Pt 1):130931. PubMed ID: 38508563 [TBL] [Abstract][Full Text] [Related]
2. Chitosan/copper sulfide nanoparticles (CS/CuSNPs) hybrid fibers with improved mechanical and photo-thermal conversion properties via tuning CuSNPs' morphological structures. Cheng C; Bao D; Sun S; Zhou Y; Tian L; Zhang B; Yu Y; Guo J; Zhang S Int J Biol Macromol; 2023 Dec; 253(Pt 5):127098. PubMed ID: 37769777 [TBL] [Abstract][Full Text] [Related]
3. Chitosan Functionalized CuS Nanoparticles Boots Gene Transfection via Photothermal Effect. Lin L; Li X; Yang Y; Jing L; Yue X; Chen X; Dai Z Curr Drug Deliv; 2017; 14(3):334-341. PubMed ID: 26743353 [TBL] [Abstract][Full Text] [Related]
4. Quaternized chitosan-stabilized copper sulfide nanoparticles for cancer therapy. Huang X; Xu C; Li Y; Cheng H; Wang X; Sun R Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():129-137. PubMed ID: 30606518 [TBL] [Abstract][Full Text] [Related]
5. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer. Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303 [TBL] [Abstract][Full Text] [Related]
6. Preparation of photothermal alginate/chitosan derivative/CuS@polydopamine composite fibers and application in desalination. Duan Y; Wang W; Jia J; Tuo X; Gong Y; Quan F Int J Biol Macromol; 2024 Oct; 277(Pt 2):134142. PubMed ID: 39059532 [TBL] [Abstract][Full Text] [Related]
7. Injectable hydrogels activated with copper sulfide nanoparticles for enhancing spatiotemporal sterilization and osteogenesis in periodontal therapy. Yang Y; Xu C; Xu S; Li Y; Chen K; Yang T; Bao J; Xu Y; Chen J; Mao C; Chen L; Sun W Biomater Sci; 2024 May; ():. PubMed ID: 38711336 [TBL] [Abstract][Full Text] [Related]
8. Chitosan-mediated green synthesis and folic-acid modification of CuS quantum dots for photoacoustic imaging guided photothermal therapy of tumor. Yu W; Yu N; Wang Z; Li X; Song C; Jiang R; Geng P; Li M; Yin S; Chen Z J Colloid Interface Sci; 2019 Nov; 555():480-488. PubMed ID: 31401480 [TBL] [Abstract][Full Text] [Related]
9. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma. Ji B; Cai H; Yang Y; Peng F; Song M; Sun K; Yan F; Liu Y Acta Biomater; 2020 Jul; 111():363-372. PubMed ID: 32434082 [TBL] [Abstract][Full Text] [Related]
10. Tailor-made PEG-DA-CuS nanoparticles enriched in tumor with the aid of retro Diels-Alder reaction triggered by their intrinsic photothermal property. Sheng J; Ma B; Yang Q; Zhang C; Jiang Z; Borrathybay E Int J Nanomedicine; 2018; 13():4291-4302. PubMed ID: 30087561 [TBL] [Abstract][Full Text] [Related]
11. Smart CuS Nanoparticles as Peroxidase Mimetics for the Design of Novel Label-Free Chemiluminescent Immunoassay. Yang Z; Cao Y; Li J; Lu M; Jiang Z; Hu X ACS Appl Mater Interfaces; 2016 May; 8(19):12031-8. PubMed ID: 27137349 [TBL] [Abstract][Full Text] [Related]
12. Sodium alginate/chitosan-coated TiO Sun S; Bao D; Zhou Y; Cheng C; Zhang S; Zhao M; Guo J Int J Biol Macromol; 2023 Jul; 242(Pt 3):124966. PubMed ID: 37244334 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma. Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments. Li X; Pan Y; Zhou J; Yi G; He C; Zhao Z; Zhang Y J Colloid Interface Sci; 2022 Jan; 605():296-310. PubMed ID: 34329981 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of copper sulfide nanoparticles decorated with folic acid/chitosan as a novel pH-sensitive nanocarrier for the efficient controlled targeted delivery of cytarabine as an anticancer drug. Hamrang R; Moniri E; Heydarinasab A; Safaeijavan R Biotechnol Appl Biochem; 2023 Feb; 70(1):330-343. PubMed ID: 35561253 [TBL] [Abstract][Full Text] [Related]
16. Thermosensitive drug-loading system based on copper sulfide nanoparticles for combined photothermal therapy and chemotherapy in vivo. Yuan Z; Qu S; He Y; Xu Y; Liang L; Zhou X; Gui L; Gu Y; Chen H Biomater Sci; 2018 Nov; 6(12):3219-3230. PubMed ID: 30255863 [TBL] [Abstract][Full Text] [Related]
17. Colorless Silk/Copper Sulfide Hybrid Fiber and Fabric with Spontaneous Heating Property under Sunlight. Wang H; Dong Q; Yao J; Shao Z; Ma J; Chen X Biomacromolecules; 2020 Apr; 21(4):1596-1603. PubMed ID: 32159952 [TBL] [Abstract][Full Text] [Related]
18. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma. Cai H; Dai X; Guo X; Zhang L; Cao K; Yan F; Ji B; Liu Y Acta Biomater; 2021 Jun; 127():276-286. PubMed ID: 33812073 [TBL] [Abstract][Full Text] [Related]
19. Copper sulfide nanoparticles with phospholipid-PEG coating for in vivo near-infrared photothermal cancer therapy. Huang Y; Lai Y; Shi S; Hao S; Wei J; Chen X Chem Asian J; 2015 Feb; 10(2):370-6. PubMed ID: 25425287 [TBL] [Abstract][Full Text] [Related]
20. Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. Guo L; Yan DD; Yang D; Li Y; Wang X; Zalewski O; Yan B; Lu W ACS Nano; 2014 Jun; 8(6):5670-81. PubMed ID: 24801008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]